13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

MTVA Stock Analysis & AI Quality Score

AI stock analysis and institutional research for MetaVia Inc. (MTVA), a Healthcare sector company. MTVA is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), MetaVia Inc. reports net income of $-3.8M, free cash flow of $-4.3M. Top institutional holders of MTVA by reported 13-F value include GEODE CAPITAL MANAGEMENT,, JANE STREET GROUP,, Aries Wealth Management, based on the most recent SEC filings. MTVA trades on the Nasdaq exchange and files with the SEC under CIK 1638287. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MTVA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MetaVia Inc. directly from SEC EDGAR.

Net Income

Q1 2026

$-3.8M

Free Cash Flow

Q1 2026

$-4.3M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Net Income

-4.0% YoY
$-13.0MFY 2025
FY21 $-15.3MFY22 $-14.0MFY23 $-12.5MFY25 $-13.0M

Operating Income

+13.7% YoY
$-13.7MFY 2025
FY21 $-15.3MFY22 $-19.6MFY23 $-15.9MFY25 $-13.7M

EPS (Diluted)

-198.8% YoY
$-7.35FY 2025
FY21 $-19.81FY22 $-43.42FY23 $-2.46FY25 $-7.35

Total Assets

-51.2% YoY
$11.1MFY 2025
FY21 $16.8MFY22 $33.5MFY23 $22.8MFY25 $11.1M

Op. Cash Flow

-45.4% YoY
$-15.7MFY 2025
FY21 $-15.1MFY22 $-11.7MFY23 $-10.8MFY25 $-15.7M

AI Insight: MTVA Financial Trends

MetaVia's operating losses have narrowed 80% from Q2 2024 to Q4 2025, but momentum reversed in Q1 2026 with net income deteriorating to –$4M.

Operating losses compressed from –$10M (Q2 2024) to –$2M (Q4 2025), signaling path toward breakeven despite revenue remaining unreported.

Operating cash burn improved materially: –$7M (Q2 2024) to –$3M (Q3 2025), though Q4 2025 and Q1 2026 saw deterioration to –$5M and –$4M.

Equity eroded 74% from $19M (Q2 2024) to $5M (Q4 2025), stabilizing slightly at $9M in Q1 2026.

Q1 2026 reversal: net loss widened to –$4M from –$2M in Q4 2025 — first deterioration in 9 months. Trend inflection warrants scrutiny.

Operating cash flow spiked to –$5M in Q4 2025 and Q1 2026 despite narrower op income; cash conversion efficiency opaque.

AI Insight: MTVA Ratio Trends

MetaVia remains deeply unprofitable with ROE deteriorating to -168.5% in Q1 2026, showing no path to profitability.

ROA improved from -91.5% in Q3 2025 to -69.4% in Q4 2025, suggesting marginal operational efficiency gains in recent quarters.

ROE worsened to -168.5% in Q1 2026 from -144.8% in Q4 2025, indicating accelerating shareholder value destruction.

No positive profitability metrics across any quarter; sustained negative ROE/ROA signals structural earnings challenges requiring strategic intervention.

TTM ROE of -144.7% and ROA of -91.2% confirm full-year losses; lack of margin/ROIC data obscures cost structure.

Get alerted when MTVA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for MetaVia Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put MTVA on your watchlist

Track score changes the day MetaVia Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is MTVA a good stock to buy?

13F Pro's AI-powered analysis of MetaVia Inc. (MTVA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MTVA are available on the MTVA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MTVA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MTVA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MetaVia Inc.'s investment landscape.